------------------------------------------------------------
[link removed]


** ICASA 2019: Navigating Prevention at the Conference
------------------------------------------------------------
November 27, 2019

Dear Advocates,

The 20th International Conference on AIDS and Sexually Transmitted Infections in Africa ([link removed]) (ICASA 2019) is coming right up, December 2-7 in Kigali, Rwanda. Find details below on select events of interest and how to follow the conference. AVAC will be there along with many of our partners participating in sessions both before and during the conference. There are several ways you can link to HIV prevention research and rollout-related events—both in-person and from afar.

For the latest, including a list of poster presentations, visit our ICASA page ([link removed]) .

ICASA 2019 HIV Prevention Research Roadmap
Amidst a wide range of topics that will be covered at the conference (full program available here ([link removed]) ), we have pulled together a roadmap of select sessions that may be of interest to those tracking biomedical prevention research and rollout. And on arrival, be sure to check out the various Networking Zone schedules in the Community Village for more great programming on prevention and more!
* Download as a PDF ([link removed]) or XLS ([link removed]) file and please let us know (mailto:[email protected]) of any other related events that should be added to the roadmap.

Biomedical HIV Prevention Forum Pre-Conference
Monday, December 2, 9:00 – 17:00 at the Kigali Marriott Hotel. Register here ([link removed]) .
* The Biomedical HIV Prevention Forum (BHPF)—co-organized by AfNHi ([link removed]) (the network of HIV prevention research advocates in Africa) and the New HIV Vaccines and Microbicides Advocacy Society ([link removed]) (NHVMAS)—puts HIV prevention research on the spotlight by providing a unique platform where participants gather to learn about progress made and best practices in biomedical HIV prevention research and development. The forum is a space for participants to share HIV prevention research related perspectives and experiences.

PEPFAR Watch
Tuesday, December 3, 8:00 – 11:00. RSVP here ([link removed]) .
* Does your country receive PEPFAR funding? PEPFAR’s annual planning process for 2020 is starting now. Join for a skills-building workshop—organized by Health GAP ([link removed]) and partners—to find out how to monitor and influence PEPFAR via updates on how activists can ensure money is aligned with community priorities; share experiences and best practices to increase accountability and share tools for organizing and data analysis.

Why Do Pre-Exposure Prophylaxis Costs Differ So Much: Methods or Setting?
Tuesday, December 3, 10:45 – 12:15 in room Jeanne Gapiya (MH4). Register at prep-costing.eventbrite.com ([link removed]) .
* This satellite session— co-hosted by the OPTIONS Consortium ([link removed]) and Jilinde ([link removed]) —will review why cost estimates and cost effectiveness of PrEP can vary so widely within and across programs, countries, and methodological approaches. Hear from a variety of programs and perspectives to identify key drivers of costs and how to make sense of estimates for use in modelling and programming.

Laying the Foundation for an HIV Cure in Africa
Tuesday, December 3, 18:30 – 20:30 in room Joel Nana (AD10)
* This satellite session— organized in partnership with the International AIDS Society ([link removed]) , the Bill & Melinda Gates Foundation ([link removed]) , Sunnylands ([link removed]) , Georgetown University ([link removed]) , AVAC ([link removed]) , and the Sub-Saharan African Network for TB/HIV Research Excellence ([link removed]) (SANTHE)—aims to strengthen engagement and support in the search for an HIV cure and allow delegates to offer important insights on optimizing a future/potential HIV cure.

20 Years After Abuja, What Next?
Wednesday, December 4, 10:45 – 12:15 in room Prof. Madeleine Okome (MH 3)
* This special session—organized by the Society for AIDS in Africa ([link removed]) —on the Abuja Declaration is a platform to evaluate the impact of various declarations on domestic funding and their implementation in Africa. The Society for AIDS in Africa (SAA) with a group of African and global HIV advocates including AVAC, has developed an African HIV Financing Scorecard in partnership with Accountability International as a means to analyse the existing funding, interrogate the gaps in required funding, and provides evidence-based advocacy messaging for action by the various stakeholders involved. The report will be released during this session and includes recommendations for an African advocacy campaign in the context of broader campaign to increase domestic funding for HIV programming.

ICASA on Social Media: Follow the conference in real-time on social media by following us on Twitter ([link removed]) and Facebook ([link removed]) —and using the official conference hashtag #ICASA2019 ([link removed]) .

Best,
AVAC

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])